We have annotated interesting sessions for Melanoma and all things advocacy on our team-up calendar here. Make sure you don't miss the most important sessions!
p.s. if you think...'this doesn't look too busy'....you are looking at the week before the congress....
Subscribe to:
Post Comments (Atom)
CHECKMATE 067 update
Last weekend, we also got the 3 year- update on CHECKMATE 067 the Ipi vs Nivo vs Ipi+Nivo study- the one that we don't like as underp...

-
QuickStart to Melanoma at ESMO for Melanoma advocates! Program and registration here
-
And the session that we all have been waiting for is about to start: adjuvant therapies in Melanoma- so for patients with Stage 3 Melanoma!...
-
BRIM8: A phase III, randomized, double-blind, placebo-controlled study of vemurafenib adjuvant therapy in patients with surgicall...
No comments:
Post a Comment